Skip to main content

Advertisement

SpringerLink
Log in

Ethnicity predicts metabolic syndrome after liver transplant

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Purpose

Post-transplant metabolic syndrome (PTMS) is associated with important causes of morbidity and mortality in solid organ transplant recipients. Our aim was to investigate predictors of PTMS in liver transplant (LT) recipients.

Methods

We randomly selected 343 adults (>18 years of age) from a large cohort of 1,262 ethnically diverse patients who received LTs during 2000–2010.

Results

Of 343 patients included, 68.2 % were male, with a mean age of 54 ± 10 years, 87 % White, and 31 % Hispanic. Prior to LTs, 6.2 % were on lipid-lowering agents and 24.5 % had BMI ≥ 30 (mean 26.9 ± 5 kg/m2). More Hispanics had diabetes before LTs compared to non-Hispanics (p = 0.037). Among those with follow-up of >6 months (n = 304) after LTs, the proportion of patients with diabetes and hypertension increased from 21.9 to 27 % (p < 0.0001), and from 11.5 to 51.6 % (p < 0.0001), respectively. Cholesterol levels increased from 150 ± 115 to 167 ± 70 (p < 0.0001). BMI remained unchanged. PTMS developed in 41 (13.5 %) and cardiovascular events in 31 (10.2 %) patients. Hispanics had higher risk of developing PTMS compared to non-Hispanics (OR 2.30, 95 % CI 1.18–4.49). Survival was not affected by PTMS (p = 0.3), ethnicity (p = 0.52), or nonalcoholic steatohepatitis as the etiology of liver disease (p = 0.50).

Conclusions

More Hispanics had diabetes before LTs (29 to 18 %, p < 0.05) and were more prone to developing PTMS after LTs compared to non-Hispanics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–1062

    Article  Google Scholar 

  2. Laryea M, Watt KD, Molinari M, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl. 2007;13(8):1109–1114

    Article  Google Scholar 

  3. Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl. 2008;14(11):1648–1654

    Article  Google Scholar 

  4. Laish I, Braun M, Mor E, et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 2011;17(1):15–22

    Article  Google Scholar 

  5. Gelson W, Hoare M, Dawwas MF, et al. The pattern of late mortality in liver transplant recipients in the United Kingdom. Transplantation. 2011;91(11):1204–1240

    Article  Google Scholar 

  6. Moore DE, Feurer ID, Rodgers S, et al. Is there racial disparity in outcomes after solid organ transplantation? Am J Surg. 2004;188(5):571–574

    Article  Google Scholar 

  7. Neal DA, Tom BD, Luan J, et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation. 2004;77(1):93–99

    Article  Google Scholar 

  8. Marchetti P, Navalesi R. The metabolic effects of cyclosporin and tacrolimus. J Endocrinol Invest. 2000;23(7):482–490

    Article  CAS  Google Scholar 

  9. Ruiz-Rebollo ML, Sanchez-Antolin G, Garcia-Pajares F. Risk of development of the metabolic syndrome after orthotopic liver transplantation. Transplant Proc. 2010;42(2):663–665

    Article  CAS  Google Scholar 

  10. Hanouneh IA, Feldstein AE, McCullough AJ, et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl. 2008;14(9):1287–1293

    Article  Google Scholar 

  11. Ferguson PJ, Lokuta MA, El-Shanti HI, et al. Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis Rheum. 2008;58(10):3264–3269

    Article  CAS  Google Scholar 

  12. Gustafsson PE, Persson M, Hammarstrom A. Life course origins of the metabolic syndrome in middle-aged women and men: the role of socioeconomic status and metabolic risk factors in adolescence and early adulthood. Ann Epidemiol. 2011;21(2):103–110

    Article  Google Scholar 

  13. Salsberry PJ, Corwin E, Reagan PB. A complex web of risks for metabolic syndrome: race/ethnicity, economics, and gender. Am J Prev Med. 2007;33(2):114–120

    Article  Google Scholar 

  14. NCEP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–2497

    Article  Google Scholar 

  15. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–2752

    Article  Google Scholar 

  16. Bhagat V, Mindikoglu AL, Nudo CG. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl. 2009;15(12):1814–1820

    Article  Google Scholar 

  17. Review of the racial and ethnic standards to the OMB concerning changes [database on the Internet] 1997. The Hispanic population:2010. Accessed 9 July 2012 at http://www.census.gov.prod/cen2010/briefs/c2010br-04.pdf

  18. Mejia A, Halff GA, Esterl R, et al. Outcome of liver transplantation in Hispanics versus non-Hispanics: is there a difference? Transplant Proc. 2002;34(4):1236–1238

    Article  CAS  Google Scholar 

  19. Yala SM, Fleck EM, Sciacca R, et al. Metabolic syndrome and the burden of cardiovascular disease in Caribbean Hispanic women living in northern Manhattan: a red flag for education. Metab Syndr Relat Disord. 2009;7(4):315–322

    Article  Google Scholar 

  20. Census rate and Hispanic. [database on the Internet] 2010. Miami Dade County Quick Facts from the US Census Bureau. Accessed 9 July 2012 at http://quickfacts.census.gov/qfd/states/12/12086.html

  21. Carrion AF, Ghanta R, Carrasquillo O, Martin P. Chronic liver disease in the Hispanic population of the United States. Clin Gastroenterol Hepatol. 2011;9(10):834–841. quiz e109–e110

    Article  Google Scholar 

  22. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27(10):2444–2449

    Article  Google Scholar 

  23. Bureau USC (2010) Income, poverty and healthy insurance coverage in the United States: 2009, Current Population Report, pp. P60–P238

  24. Yoo HY, Thuluvath PJ. Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance. Liver Transpl. 2004;10(2):235–243

    Article  Google Scholar 

  25. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet. 2002;359(9303):287–293

    Article  Google Scholar 

  26. Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40(12):1461–1465

    Article  CAS  Google Scholar 

  27. Davis JN, Le KA, Walker RW, et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr. 2010;92(6):1522–1527

    Article  CAS  Google Scholar 

  28. Wagenknecht LE, Palmer ND, Bowden DW, et al. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int. 2011;31(3):412–416

    Article  CAS  Google Scholar 

  29. Hakeam HA, Al-Jedai AH, Raza SM, Hamawi K. Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients. Ann Transplant. 2008;13(2):46–53

    CAS  PubMed  Google Scholar 

  30. Pescovitz MD, Nezakatgoo N, Lorber MI, et al. Prospective observational study of sirolimus as primary immunosuppression after renal transplantation. Transplantation. 2009;88(8):1010–1018

    Article  CAS  Google Scholar 

  31. Delgado-Borrego A, Casson D, Schoenfeld D, et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation. 2004;77(5):703–710

    Article  Google Scholar 

  32. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes Care. 2010;34(1):216–219

    Article  Google Scholar 

  33. Stegall MD, Everson G, Schroter G, et al. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation. 1995;60(9):1057–1060

    CAS  PubMed  Google Scholar 

  34. Baid S, Cosimi AB, Farrell ML, et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation. 2001;72(6):1066–1072

    Article  CAS  Google Scholar 

  35. Contos MJ, Cales W, Sterling RK, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl. 2001;7(4):363–373

    Article  CAS  Google Scholar 

  36. Everhart JE, Lombardero M, Lake JR, et al. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg. 1998;4(4):285–296

    Article  CAS  Google Scholar 

  37. Gisbert C, Prieto M, Berenguer M, et al. Hyperlipidemia in liver transplant recipients: prevalence and risk factors. Liver Transpl Surg. 1997;3(4):416–422

    Article  CAS  Google Scholar 

  38. Satapathy SK, Charlton MR. Posttransplant metabolic syndrome: new evidence of an epidemic and recommendations for management. Liver Transpl. 2011;17(1):1–6

    Article  Google Scholar 

  39. Gami AS, Witt BJ, Howard DE. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403–414

    Article  CAS  Google Scholar 

  40. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010;10(6):1420–1427

    Article  CAS  Google Scholar 

  41. Reid AE. The impact of race on liver transplant outcomes in the MELD era: still more questions than answers. Am J Gastroenterol. 2008;103(4):911–913

    Article  Google Scholar 

  42. Angulo P. Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. Hepatology. 2011;53(6):1792–1794

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, School of Medicine and Alfa Gastroenterology Institute, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil

    Claudia A. Couto

  2. Department of Surgery, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil

    Claudio L. Gelape

  3. Division of Hepatology, Center for Liver Diseases, University of Miami Leonard M. Miller School of Medicine, Miami, USA

    Iliana B. Doycheva, Paul Martin & Cynthia Levy

  4. Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, FL, USA

    Jonathan K. Kish

Authors
  1. Claudia A. Couto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudio L. Gelape
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Iliana B. Doycheva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonathan K. Kish
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paul Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cynthia Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cynthia Levy.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 22 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Couto, C.A., Gelape, C.L., Doycheva, I.B. et al. Ethnicity predicts metabolic syndrome after liver transplant. Hepatol Int 7, 741–748 (2013). https://doi.org/10.1007/s12072-012-9416-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-012-9416-x

Keywords

Search

Navigation